Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SHWARTZMAN, BORIS

NPI: 1598766081 · ATTLEBORO, MA 02703 · Anesthesiology Physician · NPI assigned 08/09/2005

$101K
Total Medicaid Paid
4,240
Total Claims
3,978
Beneficiaries
6
Codes Billed
2018-01
First Month
2022-08
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,211 $32K
2019 749 $16K
2020 769 $19K
2021 1,020 $22K
2022 491 $10K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1,566 1,481 $44K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2,064 1,928 $32K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 363 340 $16K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 93 91 $5K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 59 56 $2K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 95 82 $1K